ERK1 Protein

ERK1 (Extracellular Signal-Regulated Kinase 1)

Pathway Diagram

Overview

ERK1 (Extracellular Signal-Regulated Kinase 1)

Pathway Diagram

Overview

ERK1 (Extracellular Signal-Regulated Kinase 1), also known as MAPK3 (Mitogen-Activated Protein Kinase 3), is a serine/threonine protein kinase that plays a central role in intracellular signal transduction. As part of the MAPK/ERK signaling cascade, ERK1 transduces extracellular signals into cellular responses, regulating cell proliferation, differentiation, survival, apoptosis, and synaptic plasticity [1](https://pubmed.ncbi.nlm.nih.gov/10823812/). ERK1 is widely expressed in various tissues, with particularly high levels in the brain where it participates in learning, memory, and neuronal plasticity. [@raman2007]

The MAPK/ERK pathway is one of the most important signaling cascades in eukaryotic cells, with ERK1 (p44 MAPK) and its close homolog ERK2 (p42 MAPK) being the terminal kinases in this cascade. While ERK1 and ERK2 share significant sequence similarity and can phosphorylate many of the same substrates, they have distinct and non-redundant functions in specific biological contexts [2](https://pubmed.ncbi.nlm.nih.gov/10637608/). [@seger1995]

<div class="infobox infobox-protein"> [@kim2010]
<table> [@murray2008]
<tr><th>Protein Name</th><td>Extracellular Signal-Regulated Kinase 1</td></tr> [@mebratu2003]
<tr><th>Gene</th><td>[MAPK3](/genes/mapk3)</td></tr> [@subramaniam2010]
<tr><th>UniProt ID</th><td>[P27361](https://www.uniprot.org/uniprot/P27361)</td></tr> [@bandyopadhyay2004]
<tr><th>PDB IDs</th><td>4QTB, 4QTC, 4QTD, 4QTE</td></tr> [@huang2004]
<tr><th>Molecular Weight</th><td>~44 kDa</td></tr> [@orton2005]
<tr><th>Subcellular Localization</th><td>Cytoplasm, nucleus</td></tr> [@roskoski2012]
<tr><th>Protein Family</th><td>MAP kinase family</td></tr>
<tr><th>Expression</th><td>Ubiquitous, highest in brain, heart, skeletal muscle</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">668 edges</a></td>
</tr>
</table>
</div>

Structure and Catalytic Properties

Domain Architecture

ERK1 contains several functional domains that enable its kinase activity and regulatory functions [3](https://pubmed.ncbi.nlm.nih.gov/2177855/):

Activation Mechanism

ERK1 is activated through a conservative phosphorylation cascade:

Ras → Raf → MEK1/2 → ERK1/2

• MEK1/2 (MAPKK) phosphorylates ERK1 at:
• Threonine 202 (T202)
• Tyrosine 204 (Y204)

Isoforms

The MAPK3 gene produces multiple splice variants:

• ERK1a: Full-length isoform (402 aa)
• ERK1b: Truncated variant with alternative C-terminus

Signal Transduction

Upstream Activation

ERK1 is activated by numerous extracellular signals:

Receptor tyrosine kinases:

• TrkA, TrkB, TrkC (via Ras/Raf)
• EGFR, PDGFR, FGFR

• Metabotropic glutamate receptors
• Dopamine receptors
• Serotonin receptors

• IL-6 family receptors
• TNF receptors

• Growth factors
• Stress (UV, oxidative)
• Neuronal activity

Downstream Targets

Once activated, ERK1 phosphorylates numerous substrates [4](https://pubmed.ncbi.nlm.nih.gov/9857196/):

Transcription factors:

• c-Fos, c-Jun
• Elk-1
• CREB
• NF-κB
• Mef2

• MSK1/2 (mitogen- and stress-activated kinases)
• p90RSK (ribosomal S6 kinase)
• MNK1/2 (MAPK-interacting kinases)
• Phospholipase A2

• MAP2, Tau
• Neurofilaments

Normal Physiological Functions

Brain Function

In the central nervous system, ERK1 plays critical roles in [5](https://pubmed.ncbi.nlm.nih.gov/10545168/):

Synaptic plasticity:

• Long-term potentiation (LTP)
• Long-term depression (LTD)
• Spine morphogenesis
• AMPA receptor trafficking

• Hippocampal-dependent memory formation
• Consolidation of fear memory
• Spatial learning

• Neuronal differentiation
• Axonal guidance
• Dendritic arborization

Cellular Processes

ERK1 regulates numerous cellular functions:

• Cell cycle progression: G1/S transition
• Cell proliferation: Entry into S phase
• Cell survival: Anti-apoptotic signaling
• Differentiation: Lineage commitment
• Metabolism: Insulin signaling modulation

Role in Neurodegenerative Diseases

Alzheimer's Disease

ERK1 signaling is dysregulated in Alzheimer's disease through multiple mechanisms [6](https://pubmed.ncbi.nlm.nih.gov/11881780/):

Pathological changes:

• Aβ oligomers activate ERK1/2 pathway
• Hyperactivation of ERK1/2 in AD brain
• Altered subcellular localization

• Acute ERK1/2 activation can be protective
• Chronic activation may contribute to pathology
• Links to tau phosphorylation

• Modulating ERK1/2 activity may be beneficial
• Timing and context determine outcomes

Parkinson's Disease

ERK1 in Parkinson's disease [7](https://pubmed.ncbi.nlm.nih.gov/17434523/):

• Activation in dopaminergic neurons following injury
• Dual roles in survival and death
• Interaction with α-synuclein pathology
• Potential therapeutic target

Huntington's Disease

ERK1 signaling in Huntington's disease [8](https://pubmed.ncbi.nlm.nih.gov/18986545/):

• Mutant huntingtin disrupts ERK1/2 signaling
• Impaired nuclear signaling
• Altered transcriptional regulation
• Connection to BDNF signaling

Stroke and Ischemia

ERK1 activation following cerebral ischemia:

• Biphasic activation pattern
• Early protective phase
• Late damaging phase
• Therapeutic window considerations

Therapeutic Targeting

Challenges

Targeting ERK1 therapeutically is complex:

• Dual roles: Both protective and pathological functions
• Redundancy: Overlap with ERK2
• Ubiquitous expression: Systemic effects likely

Current Approaches

| Approach | Agent/Mechanism | Stage | Notes |
|----------|-----------------|-------|-------|
| MEK inhibitors | Trametinib, Cobimetinib | Clinical | Inhibit upstream activation |
| ERK inhibitors | Various compounds | Preclinical | Direct ERK1/2 inhibition |
| Modulators | Pathway-specific | Research | Target specific contexts |

Clinical Applications

• Cancer: MEK inhibitors for BRAF-mutant melanoma
• Cognitive enhancement: ERK1/2 modulators in development
• Neuroprotection: Pathway manipulation in research

Genetics and Expression

MAPK3 Gene

The MAPK3 gene is located on chromosome 16p11.2 and consists of 10 exons spanning approximately 8.5 kb.

Polymorphisms:

• Various SNPs associated with:
• Cognitive function
• Cancer risk
• Response to therapies

Expression Patterns

ERK1 is ubiquitously expressed:

• Brain: High in hippocampus, cortex, cerebellum
• Heart: Cardiac myocytes
• Muscle: Skeletal muscle
• Other organs: Lung, liver, kidney

Research Tools

Experimental Models

• ERK1 knockout mice (viable, subtle phenotypes)
• ERK1/ERK2 double knockouts (embryonic lethal)
• Conditional knockouts
• Phospho-mutant mice

Inhibitors

• U0126: MEK1/2 inhibitor (prevents ERK activation)
• PD98059: MEK1/2 inhibitor
• SCH772984: ERK1/2 inhibitor
• VX-11e: ERK2 inhibitor

Antibodies

• Total ERK1/2 antibodies
• Phospho-ERK1/2 (T202/Y204) antibodies
• Isoform-specific antibodies

Interaction with Other Pathways

ERK1 interacts with numerous signaling pathways:

• PI3K/Akt: Cross-talk and协同 effects
• JNK/p38: Parallel stress-activated kinases
• cAMP/PKA: Modulation by second messengers
• Calcium signaling: Calmodulin-dependent regulation

ERK1 vs ERK2

While ERK1 (p44) and ERK2 (p42) are highly similar, they have distinct functions [2](https://pubmed.ncbi.nlm.nih.gov/10637608/):

| Feature | ERK1 | ERK2 |
|---------|------|------|
| Size | 44 kDa | 42 kDa |
| Phosphorylation sites | T202, Y204 | T185, Y187 |
| Expression | Lower overall | Higher overall |
| Knockout phenotype | Mild | Embryonic lethal |
| Substrate preferences | Some unique | Some unique |

The non-redundant functions highlight the importance of studying both isoforms.

Biomarkers

Clinical Relevance

• Phospho-ERK1/2: Marker of pathway activation
• Total ERK1/2: Baseline expression
• Nuclear vs cytoplasmic: Activation status indicator

Conclusion

ERK1 is a central kinase in cellular signal transduction, playing critical roles in normal neuronal function and in neurodegenerative disease pathogenesis. Its involvement in synaptic plasticity, learning, and memory makes it an important target for understanding and potentially treating cognitive disorders. However, the dual nature of ERK1 signaling—both protective and potentially pathogenic—presents challenges for therapeutic intervention. Understanding the context-specific roles of ERK1 will be essential for developing effective neuroprotective strategies.

See Also

• MAPK3 Gene
• [ERK2 Protein](/proteins/erk2-protein)
• [MAPK Signaling Pathway](/mechanisms/mapk-signaling-pathway)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Huntington's Disease](/diseases/huntingtons-disease)
• [TrkB Protein](/proteins/trkb-protein)

External Links

• [UniProt: ERK1](https://www.uniprot.org/uniprot/P27361)
• [PDB: ERK1](https://www.rcsb.org/structure/4QTB)
• [PhosphoSitePlus: ERK1](https://www.phosphosite.org/proteinAction.action?id=8723)
• [Human Protein Atlas: MAPK3](https://www.proteinatlas.org/ENSG00000102882-MAPK3)
• [KEGG: MAPK signaling pathway](https://www.genome.jp/kegg/pathway/map/map04010)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving ERK1 Protein discovered through SciDEX knowledge graph analysis: